Retatrutide (RETA; LY3437943) is a novel triple agonist of the GIP, GLP-1 and glucagon receptors under investigation for obesity treatment.
Contact:Telegram/Signal:+44 7962637665ThreeMa:8DFP4ZRJ
Overview
موقع (أختر المنطقة)
Leaflet © OpenStreetMap contributors
Leave feedback about this